Partnership to Develop and Deliver Solutions for Interpreting Diagnostic Tests

Ingenuity Systems (Redwood City, CA, USA) has announced a partnership with Life Technologies Corporation (Carlsbad, CA, USA) to develop and deliver a joint solution for rapid, high-confidence interpretation of molecular profiling information from Life Technologies' molecular diagnostic tests.

Ingenuity Systems’ unique software and content will be provided to interpreting physicians, such as molecular pathologists and medical geneticists, in a dedicated portal, which will initially be made available for Life Technologies' emerging line of cancer diagnostic tests. Users of this interpretation portal will be able to review disease management guidelines, identify clinical trials, and find cutting-edge insights from biomedical research. The Ingenuity Systems solution will be made available in context with other software and database solutions to provide a wide range of information. Interpreting physicians will leverage the comprehensive, expert-curated “Ingenuity Knowledge Base” of biomedical content. Results of the interpretation process will then be conveyed through a reporting portal to treating physicians. While these tools will not provide medical decisions to treating physicians, they will provide contextual information that could often help identify suitable treatment options based on biological factors of an individual patient's disease.

"Advanced diagnostic tests [...] will deliver increasingly complex information about a patient's disease. It is essential that those results be made relevant to interpreting physicians by making all possible contextual information available in a single interpretation portal. We believe that Ingenuity Systems provides unique and valuable information, and we are pleased to work with them to shape the repertoire of information that the physicians interpreting our tests can employ to understand the biology of their patient's disease," said Ronnie Andrews, president, Life Technologies’ Medical Sciences division.

"With its broad technology platforms and targeted acquisitions Life Technologies is rapidly emerging as a leading provider of clinical diagnostic solutions," said Jake Leschly, CEO, Ingenuity Systems; "Our unique content and applications address a critical bottleneck in the development of the clinical diagnostic market and our partnership with [Life Technologies] enables a unique and powerful end-to-end solution for the molecular pathologist."

Related Links:
Ingenuity Systems
Life Technologies